chrisvoncsefalvay/vaers-outcomes huggingface dataset:
blood sugar was averaging 200 or even up to 300 after a vaccine or booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 62-year-old female patient received BNT162b2 (BNT162B2), on 09Jul2021 as dose 1, single (Lot number: EW0191) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Severe Osteoporosis", start date: 2020 (unspecified if ongoing), notes: Onset Date: Severe Osteoporosis 2020-2021; "She is type 2 diabetic", start date:  (unspecified if ongoing). Concomitant medication(s) included: METFORMIN taken for diabetes mellitus; GLIPIZIDE taken for diabetes mellitus. Vaccination history included: Flu shot. The following information was reported: BLOOD GLUCOSE INCREASED (non-serious) with onset Jul2021, outcome "unknown", described as "blood sugar was averaging 200 or even up to 300 after a vaccine or booster". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was reported that each time patient had a Pfizer COVID 19 vaccine or booster, she always had high blood sugars. Patient stated her blood sugar was averaging 200 or even up to 300 after a vaccine or booster. She did not have a lack of appetite and was on a low card diet to control her diabetes noting that she does not use insulin. Patient stated prior to any vaccine, her A1C went from 9 to 6.6 to 6.4 and she was doing so well her HCP cut her glipizide dose in half. After the vaccine she had to go back to her regular dose. Stated it took a while for her blood sugar to go where it usually is. Patient provided the information that she had 2 vaccines that first came out and 1 booster shortly after. Even though she took her normal dose of Glipizide 10mg twice a day, she was on 5mg, she did not tell her doctor she upped it, and it really is not helping. It is not making it come down. She is type 2 diabetic. It would go to 60 before. Further reported that when she would get each vaccine and her blood sugar would take a good 3 months before it came down, and then she would get the next one. It was bad and would get better in between. Final outcome was unknown.
New onset complex migraine headaches requiring admission to hospital for intractable pain for 1 week along with focal neurological symptoms with right sided weakness of upper and lower extremity that resolved.
On 28 November 2023 at 3:00 AM I was experiencing chest pain, sensation of chest sucking into spine and chest tightness. I arrived at the ER at 3:40
Information has been received from a health care worker concerning a patient "over 55 or 60" years of age who "two weeks ago" was vaccinated with a dose of PNEUMOVAX (lot # 651399/0486F).  Subsequently, the patient experienced redness and swelling at the site of injection.  The patient was reportedly recovering.  Additional information has been requested.
Localize red, hot circle at injection site, 4" at 24 hours, 6" at 48 hours. Holding fluid at inner arm large, puffed in moon shaped area about 1/4" high, slight fever approximately 108. Arm at 48 hr. dropped to normal. NSAID helps with discomfort.
I had local pain and was advised to no fever. March, the bottoms of my feet had a numbness and sometimes my whole feet, both feet. Just from bottom of my feet to my ankles, about quarter of my foot. The bottoms of my foot have numbness and tingling. Most of the time now.
Patient given the Pfizer vaccine as 2nd dose of Covid vaccination series on March 26, 2021.  However, patient was given the Moderna vaccine as his first dose for his Covid vaccination series back in January of 2021.   Patient assessed on March 26, 2021 at around 1137 by Nursing Lead Maxine Ojeda, RN, BSN after Pfizer vaccine was given.    During assessment,  patient showed no signs or symptoms of any adverse reaction to vaccine.  Patient stated "I feel good" "I'm doing okay".  Patient observed for an additional 45 minutes in Observation Area by qualified nursing staff.
4 1/2 x 2 1/2 area of erythema, swelling, induration upper lt arm some excoriation;
Information has been received from a physician concerning a 16 year old female who on 22-AUG-2007 was vaccinated intramuscularly with the third, 0.5 mL dose of Gardasil. It was reported that after the patient received her third dose of Gardasil she experienced severe headaches. The lot numbers for all three doses of Gardasil are not known. The date of administration for the first and second dose of Gardasil are not known. The patient sought unspecified medical attention. The patient's parent had contacted the physician. At the time of the report, the patient had not recovered. Additional information has been requested.
a patient who received the first dose when they were 16 in September 2019 and just came in for his second dose today on 8/26/23; This spontaneous report was received from pharmacist and referred to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  In September 2019, when the patient was 16, was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, vaccination scheme, anatomical location, dose description, lot #, expiry date, and route of administration were not provided).  On 26-AUG-2023, the subject went for the second dose (inappropriate schedule of product administration). At the reporting time, the outcome of the event was unknown.
Fever, chills, headache, Body ache, diarrhea, muscle ache, backache, joint pain, muscle soreness, stiffness
Here with complaints of side effects with the 3rd Moderna vaccine given 09/19/2021. She has a sore, red, and tender right arm at and below the site of the injection. She is also having swelling under her right under arm.  Swelling came the next day and the red arm came 2 days later.
About two weeks afterwards I start having Vertigo. I had it before but it has been about 11 years since I last had it.  Still having some light headiness and dizziness.
From 1:30 am to 7:30 am 4/10/2021 Tachycardia  Tightness in chest Possible Difficulty breathing ?? Fingers and tongue tingling or numb Dizzy and fainting if attempt to get up or sit up ( needed ambulance but could not unlock door  or call) Severe pain everywhere Feet cold and numb( no fever) After 7:30  am 4/10/2021  just very mild pain,fever,fatigue.
sore and achy arm; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of MYALGIA (sore and achy arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history reported) since an unknown date. Concomitant products included LOSARTAN, ROSUVASTATIN, CALCIUM, VENLAFAXINE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (sore and achy arm). On 16-Mar-2021, MYALGIA (sore and achy arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-075084 (Patient Link).
I had the J&J injection in the late afternoon.  By evening, I began spiking a fever. I had a fever and chills - sweating, aches and pains all over body, throbbing leg, and a massive headache/migraine for almost 3 days.  By the 3rd day, I began feeling better.  My head hurt on and off through out the day. By the 4th day, I felt much better.
diarrhoea; Searing headache; This is a spontaneous report from a contactable consumer (patient).A 52-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Expiration date: Unknown; Lot Number: EL3247), via unspecified route of administration in the right arm On 01Mar2021 at 09.00 (at the age of 52-years-old) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no known allergies.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccination included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE,Solution for injection,Lot Number: EL3247; Expiry date: Unknown), via an unspecified route of administration in the left arm on 08Feb2021 at 09:00 as single dose for COVID-19 immunization. On 01Mar2021 (at 20:00), after 11hours from vaccination, the patient experienced Searing headache, diarrhoea. The patient did not receive any treatment.The outcome of the events was recovered on unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Oxygen saturation low; Difficulty breathing; Hallucinating; Incoherent; Wheezing; does not recall anything after that for the next 12 hours; Extreme Painful L arm; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of OXYGEN SATURATION DECREASED (Oxygen saturation low), DYSPNOEA (Difficulty breathing) and HALLUCINATION (Hallucinating) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Medical history was not reported.). Concurrent medical conditions included Type 2 diabetes mellitus and Asthma. Concomitant products included INSULIN ASPART and INSULIN DETEMIR (LEVEMIR) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced OXYGEN SATURATION DECREASED (Oxygen saturation low) (seriousness criterion hospitalization), DYSPNOEA (Difficulty breathing) (seriousness criterion hospitalization), HALLUCINATION (Hallucinating) (seriousness criterion hospitalization), INCOHERENT (Incoherent), WHEEZING (Wheezing), AMNESIA (does not recall anything after that for the next 12 hours), PAIN IN EXTREMITY (Extreme Painful L arm) and CHILLS (Chills). On 21-Mar-2021, OXYGEN SATURATION DECREASED (Oxygen saturation low), DYSPNOEA (Difficulty breathing), HALLUCINATION (Hallucinating), INCOHERENT (Incoherent), WHEEZING (Wheezing), PAIN IN EXTREMITY (Extreme Painful L arm) and CHILLS (Chills) had resolved. At the time of the report, AMNESIA (does not recall anything after that for the next 12 hours) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, COVID-19: negative (Negative) Negative. On 17-Mar-2021, Oxygen saturation decreased: abnormal (abnormal) oxygen 72.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.
soreness on his arm/He said his left arm was barely sore after receiving the COVID-19 Vaccine; This is a spontaneous report from a contactable consumer reporting for himself. A 23-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL1283/expiration date: Apr2021), via an unspecified route of administration, on 18Jan2021 16:00 (at the age of 23 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history and concomitant medication were reported as none. Past vaccine history included the patient received a flu vaccine injection on Oct2020 and he could barely lift his arm up after receiving a flu vaccine injection and on Nov2020 approximately 5 weeks ago, the patient received PPSV23 vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Jan2021, the patient experienced soreness on his arm, started slowly, about 2 hours post COVID-19 vaccination. He said his left arm was barely sore after receiving the COVID-19 Vaccine. The soreness went away completely on 19Jan2021. The patient did not receive any treatment for the event. The outcome of the event soreness on his arm was recovered on 19Jan2021.
side effects are: horseness, whooping cough, loss of appetite, tiredness and wheezing.  Do I let it run its course or?
bad head, body, arm, joint and leg ache; bad head, body, arm, joint and leg ache; bad head, body, arm, joint and leg ache; bad head, body, arm, joint and leg ache; This is a spontaneous report received from a contactable reporter (Consumer) for a Pfizer sponsored program. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 18Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19 positive", start date: 10Dec2020 (unspecified if ongoing), notes: was tested Covid19 positive on 10Dec2020. The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), PAIN (non-serious), PAIN IN EXTREMITY (non-serious), ARTHRALGIA (non-serious), outcome "unknown" and all described as "bad head, body, arm, joint and leg ache". Relevant laboratory tests and procedures are available in the appropriate section. Additional Information: The reporter was tested COVID-19 positive on 10Dec2020. The reporter had the first dose on 18Mar2021 but experienced symptoms of bad head, body, arm, joint and leg ache after the first dose. The reporter was asking if the 2nd dose will be stronger than the first dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 15-FEB-2016 the patient as vaccinated with an improperly stored dose of PROQUAD (Merck) (lot # L030587, expiration date 10-FEB-2017, dosage and route not specified). It was reported that the vaccine was stored at -13.7 degree Centigrade for 15 hours. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
30 hours post vaccination the evening of 10/24/2021 my lower back hurt, and I was getting a headache. On Saturday morning 10/30/2021 I was getting no relief from migraine medication. The intensity of the headache increased, and it included very strong muscle spasms in my neck. I called the doctor on call, and he prescribed methylprednisolone a packet of 4 ml 21 tablets over the course of 6 days. I will be finished with them 11/04/2021. He also told me to up my migraine treximet from 3 instead of 1 time a day. I also take imatrix 25 mg. I took that on Friday before I called the doctor. I have not recovered from the headaches and neck spasms. The intensity has decreased. I still can't drive. I contacted the doctor because my symptoms have not resolved, and they scheduled me an appointment for 11/04/2021 in the morning.
tested positive for COVID; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (tested positive for COVID) in a 78-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027e22a) for COVID-19 vaccination.     The patient never had COVID positive test or diagnosis in the past before. The patient had no history relating to mentioned adverse event and both Acute and Chronic illnesses at the time of vaccination.  Previously administered products included for Product used for unknown indication: INFLUENZA VACCINE on 24-Aug-2022; for Hormone replacement therapy: femhrt. Past adverse reactions to the above products included No adverse event with INFLUENZA VACCINE; and TIA with femhrt. Concurrent medical conditions included Arthritis (patient experienced achy joints in the past.), Spinal disorder NOS and Drug allergy (to some medications not true allergies but side effects).    On 27-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 31-Oct-2022, the patient experienced COVID-19 (tested positive for COVID). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, COVID-19 (tested positive for COVID) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2022, Oxygen saturation: 93 % and 91 %. On 31-Oct-2022, Influenza virus test: Negative. On 31-Oct-2022, SARS-CoV-2 test: Positive.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant information provided Patient received 1st dose on 14Jan2021 with lot 041l20a Patient received 2nd dose 11Feb2021 with lot 024m20a Patient received1st booster 25Oct2021 with lot 0760217 Patient received 2nd booster 20April2022 with lot 005m214 It was reported that following vaccination within 18 hours of vaccination patient started to experience: was very sick, clearing her throat briefly, headache, cough, joints aching, fatigue and weakness. The patient sought medical care to get testing done. Patient tested for COVID on 31-Oct-2022 and on 01-Nov-2022 she was told she was positive.   This case was linked to MOD-2022-667354, MOD-2022-667365 (Patient Link).
>than 35 days since first dose; This spontaneous case was reported by a consumer and describes the occurrence of INCOMPLETE COURSE OF VACCINATION (>than 35 days since first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCOMPLETE COURSE OF VACCINATION (>than 35 days since first dose). At the time of the report, INCOMPLETE COURSE OF VACCINATION (>than 35 days since first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported by reporter Treatment information was not provided by reporter
Pt developed "rash on trunk, neck and face" since Feb 9, 2006.  Now scabbing in spots.  Came to office to confirm whether chicken pox.  Confirmed by Dr.
Pt received vaccine and then went to observation area. While in the obs area patient began to complain of itching and ringing. 30 minutes later the patient felt better. Pt went home with no symptoms.
headache; coughing at night; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and COUGH (coughing at night) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Headache and Coughing.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache) and COUGH (coughing at night). At the time of the report, HEADACHE (headache) and COUGH (coughing at night) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Received second shot in left deltoid 4/3, mylagia 4/4, nausea 4/5, chest pressure and shortness of breath started 4/6
This spontaneous report was received from a healthcare worker referring to unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date the patient was vaccinated with VARIVAX (dose and route were not reported), lot # M041514 and expiry date: 11-OCT-2018 for prophylaxis. The vaccine was exposed to temperature of 15 to 46 Fahrenheit for 75 minutes. There was a previous temperature excursion of 15 to 46 Fahrenheit for 53.5 hours. No adverse effects and no product quality complaint (PQC) was reported. No further information provided. This is one of the several reports from the same  reporter. Additional information has been requested.; Sender's Comments: US-009507513-1707USA007237: US-009507513-1707USA007238: US-009507513-1707USA006714:
Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of MMR. One month after the patient developed a swollen parietal gland. At the time of the report the patient's swollen parietal gland persisted. Unspecified medical attention was sought. No product quality complaint was involved. The pharmacist did not have any other information about the patient. Additional information is not expected.
Per Patient she was having the Edema and Shortness of Breath prior to her Vaccination. She had an Echocardiogram done at the cardiology office. Then she had a second one done approx.  a month later and per patient there was a significant difference in the results. She believes this is the outcome of her getting the Covid-19 vaccine. She did not inform our office until today 02/11/2022 of this. She had the injection almost 8 months ago.